Clinical biochemistry forms the backbone of every clinical specialty, as up to 70% of clinical diagnosis requires the input of laboratory investigations. The division of Clinical Biochemistry is the integral bridge between patients and clinicians.
We welcome you to our Annual Meeting titled “Advances in Biochemistry &Cancer Diagnostics”. This title depicts our practice and vision to teach and learn at Tata Memorial Hospital. This CME is aimed to provide a platform for all involved in laboratory medicine and laboratory diagnosis for discussion and keeping upraised about the latest developments and advances in the field.
The CME schedule on first day will cover lectures with above aim in mind and the second day is a workshop that will appeal to the novices in laboratory medicine whereby we shall cover basic principles of instrumentation, operation of automated machine, special techniques and serum protein electrophoresis.
The Department of Clinical Biochemistry, Tata Memorial Hospital has a high throughput laboratory that processes over 2000 to 3000 patient samples per day which includes biochemical assays, immunoassays, assays for tumor marker and serum protein electrophoresis. We have experience with high end analyzers in routine clinical medicine and highly trained staff.
All laboratory physicians, biochemists, clinical pathologist, postgraduates in pathology/ biochemistry, laboratory technologist and clinical scientist. We are in process of applying for four MMC credit points.
Dr. Tanuja Shet
Dr. Kinjalka Ghosh
Dr. Shrikant Raut
Dr. Nikhil Choudhary
|For physical attendees
(02:15 pm – 04:15 pm)
|For virtual attendees
(02:15 pm – 04:15 pm)
|Virtual lecture on Guidelines for the Initial Detection of Monoclonal Immunoglobulin Proteins
By: Prof. (Dr) David Keren
Professor Of Pathology
University of Michigan Medical School, Michigan
|Laboratory Tour and Electrophoresis Workshop
(02:15 pm – 03:15 pm)Batch 01
|Serum Protein Electrophoresis and Immunofixation: Chasing the “bands” on gel and capillary
Dr. Satyprakash Rane
Department of Biochemistry Seth G.S Medical College & KEM Hospital, Mumbai
Mr Pandit Pawar
Mr Nilesh Bobade
Tata Memorial Hospital, Mumbai
|Laboratory Tour and Electrophoresis Workshop
(03:15 pm – 04:15 pm)Batch 02
Dr. Lakshmi V. Ramanathan is the Service Chief of Clinical Chemistry in the Department Of Laboratory Medicine at Memorial Sloan Kettering Cancer Center in New York City.
She obtained her PhD in Nutritional Biochemistry and Metabolism at Massachusetts Institute of Technology in Cambridge, Massachusetts, USA.
Her research interests include laboratory automation and biomarkers in cancer diagnostics. She is very active in the American Association of Clinical Chemistry. She was the past chair of the New York metro section, the Science Practice Core Committee of AACC and is currently a member of the Awards Committee and the Global Quality Improvement Asia-Pacific Working Group.
Ravinder J. Singh, Ph.D., is the director of the Mayo Clinic Endocrine Laboratory. He has a focused area of investigation that has broad applicability to the field.
Annalise Zemlin is Head of Division of Chemical Pathology (National Health Laboratory Service and University of Stellenbosch) at Tygerberg Hospital, a tertiary care hospital associated with the University of Stellenbosch. She graduated from the University of Stellenbosch with an MMed in Chemical Pathology in 2004 after receiving her FCPath (SA) Chem in 2003. She obtained her PhD in December 2016.
Her main research interests are Evidence-Based Laboratory Medicine, Laboratory Management and Operational Research, Diabetes Mellitus and Cardiovascular Disease, Point of Care testing, HIV and Inflammation and more recently Laboratory Investigation and Outcomes in COVID-19. She is the chair of the IFCC committee on Evidence-Based Laboratory Medicine and a previous member of the IFCC Public Relations committee. She is involved in module and curriculum development and training of undergraduate students, teaching and supervising of Masters and PhD Students, and is Module coordinator of the Laboratory Management Module in Pathology (MMed). She is also chair of the Audit Committee and has performed numerous laboratory audits with other countries in Africa. She is a founder member of the College of East, Central and Southern Africa which was founded in Kampala in 2010.
Dr.Seema Bhargava has an MBBS degree from Government Medical College, Srinagar, J&K (Kashmir University), DNB from Lady Hardinge Medical College, New Delhi, and PhD from Sir Ganga Ram Hospital (SGRH) and Jamia Millia Islamia, New Delhi with a short post-doctoral stint at University of Louisville, Kentucky, USA.
Research: Dr.Seema has worked in the Department of Biochemistry at SGRH, New Delhi, since 1992. Her research on homocysteine has resulted in the implementation of several translational aspects at SGRH in diagnostics and management of vascular disease. Her research continues to focus on identification of clinically relevant biochemical markers and their applications in various areas of medicine like neurology, Alzheimer’s disease, cardiovascular disease, sepsis, immunology, diabetes with special reference to micronutrients deficiency and toxicity, e.g. vitamin B12, lead, etc. Awards: International Academy of Cardiovascular Sciences applauded her by ‘James Willerson Clinical Award’ in 2013. She is also the recipient of many other awards and fellowships [FRCPath from Royal College of Pathologists, London, UK (2019) and FACBI from Association of Clinical Biochemists of India (ACBI) 2018]. She has also received the ‘Dharam Vira Award For Excellence 2014’ for meritorious services rendered at SGRH, New Delhi, and Gold Medal of ‘GRIPMER Best Publication 2012’.
Publications: Dr. Seema has over 40 publications in national and international indexed journals and several chapters in various books (Biochemistry, Cardiology, National Digital Library). She has also authored a book titled “Clinical Applications of Homocysteine” published by Springer International in 2018.
Academic: She has guided several PhD and DNB scholars, and MSc, BSc, nursing and DMLT students. She is also on the editorial board of IJCB [Indian Journal of Clinical Biochemistry], CMRP [Current Medicine Research and Practice] and JNNSc [Journal of Nature and Natural Sciences] and a reviewer for several other international indexed journals.
Memberships and posts in organizations: Dr.Seema has also held executive posts in several national academic associations, e.g. Association of Clinical Biochemists of India [ACBI current post: Vice-President, earlier post: North Zone Representative], Indian Academy of Biomedical Sciences [IABS post held: North Zone Executive], Consortium of Accredited Healthcare Organizations [CAHO current post: Chairperson, Diagnostics Division], life member of Indian Society for Lead Awareness and Research [InSLAR], International Society of Inborn Errors of Metabolism [ISIEM founder member], Indian Society of Atherosclerosis Research [ISAR-DC (Delhi Chapter) current post: Secretary], Editorial Board of Current Medicine Research and Practice [member], Member - Steering Committee, Department of Biotechnology, New Delhi, India. She has organised many CMEs and conducted several webinars as well. She is a full member of the Evidence Based Laboratory Medicine Committee of the International Federation of Clinical Chemistry [IFCC EBLM-C] and has also been chosen for the Visiting Lecturers program (VLP).
Quality Assurance: Dr.Seema is a lead assessor and technical assessor for NABL [National Accreditation Board for testing and calibrating Laboratories] and also a member of its Technical as well as Core Committees for Accreditation. She is the Course Director for a course on “Total Laboratory Quality Management and Internal Auditor-ISO 15189:2012” conducted by GRIPMER.
Dr. Barnali Das is the technical committee member in International Federation of Clinical Chemistry & Laboratory Medicine's (IFCC's) six members Committee on Standardization of Thyroid Functions Tests (C-STFT) worldwide and the corresponding Member for IFCC Committee for Reference Interval & Decision Limit (IFCC C-RIDL). She is National Accreditation Board for Testing & Calibration Laboratories (NABL) Assessor and College of American Pathologist (CAP) Inspector. She is also the Joint Secretary of Consortium of Accredited Health Care Organization (CAHO). Dr. Barnali Das has done her M.B.B.S. from Lady Hardinge Medical College, Delhi and MD and DNB (Biochemistry) from Maulana Azad Medical College, Delhi. Subsequently, she has done management development training from IIT Bombay, and also pursued courses in Clinical Trial and PGDM in Hospital & Health Care Management. She has done Green Belt (Six Sigma) from Indian Statistical Institute. Dr. Barnali is recipient of two oration awards and seven international and five national awards & grants from American Association of Clinical Chemistry, International Federation of Clinical Chemistry & Laboratory Medicine, Asia Pacific Federation of Clinical Biochemistry, Reliance Group Corporate Social Responsibility (The Woman of Substance Award), Association of Clinical Biochemists of India, Association of Medical Biochemists of India. Dr. Barnali has many publications in high impact factor international journals & national journals (recent ones are European Thyroid Journal, Clinical Biochemistry etc). She has delivered 92 invited talks & plenary lectures; 2 orations and chaired 37 sessions in conferences in different countries. She has authored one book and contributed many articles & views in magazines and newspapers (Times of India first page, Hindustan Times, Express Health Care, CLN News etc.). Through her research, she has proposed a novel index on coronary artery disease named Lipid Pentad Index (LPI), which was published in high impact international journal and highlighted in many newspapers & newsletters and acclaimed by the International Atherosclerosis Society & American association of Clinical Chemistry.
Dr. Amrita Cheema, PhD, is a professor of Oncology and Biochemistry at Georgetown University Medical Center. She also co-directs the Waters Center of Innovation in Metabolomics at GUMC. Her extramurally funded research program is focused on delineating small molecule biomarkers that are predictive of exposure to ionizing radiation as well for adverse outcomes of radiotherapy. Her laboratory has also developed several tools and workflows for furthering metabolomics based molecular phenotyping for clinical and translational research. Dr. Amrita’s work has been documented in more than 45 peer reviewed publications and 5 biomarker patents.
Dr. David Keren is the Professor of Pathology, The University of Michigan Medical School, Ann Arbor, Michigan. He is also the CEO and President of InheRET Corporation. He obtained his MD in Pathology from University of Illinois, College of Medicine, USA
He has been a Consultant, Special Advisory Panel on Capillary Zone Electrophoresis, Beckman Coulter, 2004 and Sebia, Inc, Norcross, GA, 2012-2013 He was a Member, Immunology Devices Panel of the Medical Devices Advisory Committee, Department of Health & Human Services, Food and Drug Administration, 2001-2019 He has received various honors and awards like, H.P. Smith Award for Distinguished Pathology Educator, American Society for Clinical Pathology, 2017. Teaching awards like, American Association of Clinical Chemistry Outstanding Lecture Award, 1990, 1992, 2007, 2010, 2013, 2014, 2015